Clinical Trial

Effects of Mindfulness-Based Self-Efficacy Development Program on Postmenopausal Women

Study acronym: MOPKA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 22, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this randomized controlled clinical trial is to evaluate the effects of a mindfulness-based self-efficacy development program on menopausal symptoms and quality of life in postmenopausal women. The main questions it aims to answer are: Does the mindfulness-based program reduce the severity of menopausal symptoms? Does the mindfulness-based program improve the quality of life of postmenopausal women? Does the mindfulness-based program significantly increase participants' overall self-efficacy? The researchers will compare whether there are differences between the mindfulness-based training program applied to the intervention group and the control group in terms of menopausal symptoms, quality of life, and self-efficacy scores. The main tasks that will be asked of the participants are as follows: Those in the intervention group will participate in a face-to-face mindfulness-based self-efficacy development program, each session lasting at least 120 minutes, once a week for 8 weeks, with a maximum of 10 people per group. The control group will not receive any intervention. Participants in both groups will be evaluated with a personal information form and measurement tools such as the Menopause Symptoms Assessment Scale, the Menopause Specific Quality of Life Scale, and the General Self-efficacy Scale.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-14.
Trial Details
NCT Number NCT07034885
Lead Sponsor Nurcan Gökgöz
Conditions Postmenopausal Period, Menopausal Symptoms, Quality of Life, Stress Management, Self-Efficacy
Enrollment 70 participants
Start Date 2025-09-15
Primary Completion 2026-01 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-07-22